We target healthcare assets with significant clinical value and strong barriers to entry that are marketed by some of the world's largest pharmaceutical companies. We also look for assets that will produce sustainable revenues over an extended period of time. Our investments span the pharmaceutical, biotechnology, specialty pharmaceutical, and medical device/diagnostics sectors.

Select Investments:


Previous Investments: